Pfizer's Covid-19 Success Bodes Very Well For Moderna

While Pfizer's surprisingly strong initial Covid-19 vaccine efficacy readout likely marks the beginning of the end of the Covid-19 pandemic, it probably doesn't mean too much for Pfizer stock, given the limited potential profits and challenges with distribution. In fact, we think that the strong...